Researchers developed advanced imaging strategies using intelligent micro/nanomotors, enabling enhanced detection sensitivity and real-time tracking of subcellular events. The proposed approach integrates MNMs as dynamic contrast agents for multimodal diagnostics, providing a theoretical framework for bioimaging technologies.
Researchers have developed a new PET imaging agent that can distinguish true tumor response from inflammation during immune checkpoint inhibitor therapy. This breakthrough has the potential to improve early treatment assessment and patient outcomes.
A low-cost smartphone imaging system called mDOC combines autofluorescence and white light imaging with machine learning to accurately identify oral lesions requiring specialist referral. The system achieved an area under the ROC curve of 0.778, outperforming dental providers in sensitivity and specificity.
Studies have found that men with advanced prostate cancer can benefit from continuing PSMA therapy despite early PSA rise, while a new PET/CT scan may improve surgery decisions in pancreatic cancer. Molecular imaging advancements also hold promise for distinguishing aggressive kidney cancers and guiding treatment decisions.
The Programmable Liquid-crystal Active Coronagraphic Imager for the DAG telescope (PLACID) will improve detection and direct imaging of exoplanets using liquid crystals. It can adapt to complex mask configurations, enabling direct imaging of circumbinary planets and proto-planetary discs.
A recent study found a small-but-significant link between exposure to radiation from medical imaging and blood cancers in children and adolescents. The study concludes that while ionizing radiation is a carcinogen, the benefit-to-risk ratio favors CT imaging of children when justified and technique minimizes adverse effects.
A new 3D imaging technique combines intensity diffraction tomography with adaptive optics to track subcellular structures over extended periods. This approach achieves high spatiotemporal resolution and molecular specificity, enabling the study of cellular dynamics.
A new fast-hyperspectral imaging remote sensing technique enables precise imaging and quantification of nitrogen dioxide (NO₂) and sulfur dioxide (SO₂) emissions from marine vessels. The system achieves accurate plume categorization, outline identification, and detailed observation of trace gas distribution.
A new clinical guideline has been issued for 18F-flurpiridaz PET myocardial perfusion imaging, providing recommendations for patient selection, imaging protocols, and interpretation of results. The guideline aims to enhance diagnostic accuracy and optimize resource utilization for the evaluation of coronary artery disease.
The use of atomic magnetometers in electromagnetic induction imaging (EMI) has greatly improved its low-frequency sensitivity. This technology enables the exploration of challenging applications such as through-barrier imaging and organ imaging, expanding EMI's potential in medicine and other fields.
A study published in The New England Journal of Medicine found that nearly 4 million children and adolescents were at higher risk of developing blood cancers due to radiation exposure from medical imaging. The researchers estimated that up to 10% of pediatric blood and bone marrow cancers may be attributable to radiation exposure.
Researchers developed DF-FPDT to address low-frequency loss from non-matched illumination in live-cell imaging, enabling high-resolution and high-contrast 3D reconstructions. This breakthrough technique leverages non-matched illumination to enhance structural details without additional hardware or post-processing.
New PET imaging agents show promise for detecting thyroid and neuroendocrine tumors, as well as reversing fibrosis in the heart. Researchers also explored tau PET scans for Alzheimer's detection and SSTR PET/CT for meningioma diagnosis. These advancements hold potential for improving cancer treatment and patient outcomes.
Researchers have developed a motion-compensation method that allows single-pixel imaging to capture sharp images of complex dynamic scenes. The new approach improves image quality and video smoothness in various scenarios, including surveillance and medical diagnostics.
Researchers have developed new PET tracers to monitor immune responses and inflammation beyond the lungs throughout the course of SARS-CoV-2 infection. These breakthroughs offer a new way to visualize changes in lymph nodes, spleen, and bone marrow, supporting faster and more comprehensive imaging.
Researchers have published three studies using new imaging approaches to detect and treat various types of cancer. These advancements include positronium lifetime tomography for sharper scans, targeted radiotherapy for sarcoma patients, and biomarkers for endometrial cancer diagnosis.
Researchers propose a passive quantum compressed sensing-based single-photon dynamic imaging technique for long-distance drone detection. The method improves imaging sensitivity and robustness against noise, enabling frequency-domain sparse signal reconstruction based on discrete photon detection events.
The Peking University team developed a novel triangle structured illumination microscopy (SIM) that enables gentler, sustained super-resolution live-cell imaging. The new method achieves an unprecedented kilo-Hz speed and half-day-long duration, allowing for the study of complex biological processes with higher data throughput.
Researchers developed a radiotracer targeting CD24 protein on liver tumor cells, accurately detecting tumors in mice. PSMA PET/CT scans also tracked prostate cancer spread in patients, predicting shorter survival for those with interlesional progression.
A new deep learning model enhances handheld 3D medical imaging by automatically tracking transducer motion without external sensors. The model produces more realistic 3D US images and can reconstruct blood vessel structures using ultrasound and photoacoustic data.
The researchers developed a new imaging technology that enables the creation of high-resolution 3D images of an entire mouse body, including its peripheral nervous system. The technology allows for the mapping of nerve routes at the subcellular level, providing insights into neural regulation and disease mechanisms.
A new breast scan system combines photoacoustic and ultrasound imaging to produce clear 3D images of common breast cancer subtypes. The system, called OneTouch-PAT, takes less than a minute to complete and excels at detecting suspicious lesions in women with dense breast tissue.
Researchers at Vanderbilt University Medical Center have developed a safe and effective fluorescent imaging agent that can assist surgeons in visualizing nerves during head and neck surgery. The agent, bevonescein, allows for intraoperative nerve-specific fluorescence visualization, reducing the risk of nerve injury.
A new prototype imaging system combines light-emitting diodes (LEDs) with hyperspectral imaging technology to create detailed maps of tissue properties invisible to conventional cameras. The system shows promise for cancer detection during endoscopy, achieving real-time speeds and high-quality data comparable to reference systems.
Imaging genomics combines clinical images and human genetic data to understand diseases. The field is shifting from validation to systems biology modeling, enabling the discovery of new biomarkers and therapeutic targets.
A new AI-assisted technique called PACT has been developed to help differentiate between suspicious and healthy tissue in breast imaging. The method, which combines light and sound into a single modality, performs as well as or better than conventional techniques like mammography and MRI.
A novel PET imaging approach can accurately detect and monitor Mycobacteroides abscessus lung infections. The technique uses 11C-PABA PET to differentiate between bacterial infection and inflammatory diseases.
A new PET/CT imaging technique visualizes activated fibroblasts in the heart muscle, detecting multiple forms of cardiomyopathy. The method provides valuable insights into disease progression and helps improve risk stratification for patients with non-ischemic cardiomyopathy.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has selected 7 new Fellows for their exceptional achievements in the field. The SNMMI Fellowship is a prestigious recognition of outstanding service to the society and excellence in scientific discovery, educational efforts, or clinical practice.
A novel molecular imaging agent targeting glypican-3 has demonstrated high sensitivity and specificity in detecting hepatocellular carcinoma (HCC), including tumors smaller than one centimeter. The agent provides high-contrast images of GPC3-positive liver tumors, offering a promising new tool for early diagnosis and staging of HCC.
Julie C. Price has been recognized for her groundbreaking work on PET imaging techniques and multimodal imaging for translational neuroscience. She aims to advance early detection of Alzheimer's disease-related tau protein deposition.
A novel integrated molecular imaging approach using dual PET/MR and PET/CMR techniques enables precise localization of heart damage and accurate identification of disease subtypes. This method also provides direct evidence supporting surgery as a cardio-protective intervention in patients with primary aldosteronism.
A newly developed cardiac PET imaging technique offers a simpler way to detect significant coronary artery disease by eliminating the need for complex scanning protocols. The technique has been shown to accurately estimate myocardial flow reserve during both exercise and pharmacologic stress, making advanced heart imaging more accessible.
Advanced software is used to measure radiation dose distribution throughout the body, ensuring patient safety and tailoring treatments. Post-therapy imaging helps identify complications and guide clinical decisions, ultimately optimizing treatment outcomes and protecting patients.
The UCLA team introduces a framework for arbitrary 3D point spread function engineering, enabling adaptive optical imaging systems with precise control of light distribution in three dimensions. This development has significant implications for advanced imaging modalities, such as snapshot 3D multispectral imaging.
New radioimmunotherapy approaches show promise against advanced breast cancer and prostate cancer. Additionally, new imaging tools enhance cancer detection and diagnosis, while a proposed standard improves lesion interpretation. Cost-effectiveness studies also support novel therapies for rare digestive cancers.
Researchers studied obesity's impact on breast cancer, linked imaging patterns to lung disease survival, and tracked hidden inflammation in COVID-19 patients using advanced PET imaging techniques.
A randomized controlled trial found that additional imaging techniques such as fast MRI and contrast mammography can detect early-stage cancers in women with dense breasts that were missed by mammograms. The study showed a cancer detection rate of 1.7% for fast MRI and 1.9% for contrast mammography, compared to 0.4% for ultrasound.
Scientists have developed a novel pretargeting system to boost cancer imaging using DARPin G3, which achieves specific tumor targeting with reduced kidney and liver uptake. GRPR is emerging as a powerful tool for both imaging and treatment in various cancers, offering personalized cancer care across multiple tumor types.
Dr. Tarek Hanna joins UMSOM from Emory University School of Medicine with expertise in emergency and trauma imaging, clinical operations optimization, and faculty development. He will advance clinical excellence and expand radiology services across central Maryland.
Scientists have developed a new PET imaging compound to visualize key enzymes in mental health, enabling multiple same-day scans. Additionally, researchers have discovered that PET scans can detect not only HER2-positive but also HER2-low breast cancer lesions.
Researchers have developed new imaging tools to visualize protein changes in Alzheimer's, heart and lung issues in long COVID patients, and a common marker in nasopharyngeal cancer. A first-in-human trial tests a next-generation radiopharmaceutical for advanced prostate cancer.
A team from Peking University achieved a major breakthrough in imaging 15 cellular structures simultaneously using lipid membrane probes, dual-color spinning-disk confocal microscopy, and deep learning. This method enables real-time, long-term organelle tracking with improved efficiency and reduced phototoxicity.
Researchers have discovered important differences in how a targeted therapy behaves in the body over time, allowing for more tailored treatment strategies. A new PET/CT scanner also shows promise for accurate imaging with dramatically reduced exposure, especially for sensitive patients like children or those needing repeated scans.
A new imaging technique developed by IU scientists allows for the visualization of 25 cellular markers in intact bone marrow tissue without disruption. This advancement could support future drug development and therapies for conditions involving bone marrow.
Researchers have developed novel imaging agents targeting shared proteins in triple-negative breast cancer tumors, successfully highlighting various tumor types using PET/CT scans. Additionally, a new brain imaging technique shows promise in identifying complex brain diseases like progressive supranuclear palsy and corticobasal degener...
A novel cannula delivery system allows repeated, nondisruptive delivery of imaging agents to the mouse brain during long-term multiphoton microscopy. This innovation enhances longitudinal studies on brain function, disease progression, and potential treatments.
The SNMMI Mars Shot Research Fund has awarded a $100,000 fellowship to Dr. Randy Ye for his research on FAPI PET imaging for detecting invasive lobular carcinoma. The study aims to assess the ability of FAPI PET and FDG PET to detect tumors and evaluate its impact on patient care.
Two new studies published in The Journal of Nuclear Medicine explore innovative approaches to treating melanoma with radiation therapy and enhancing brain PET imaging. A third study validates an AI network for brain tumor imaging, demonstrating promising results.
The new Keck Medicine of USC – Newport Beach Radiation Oncology and Imaging Center offers biology-guided radiation therapy, using up-to-the-minute signals to track and treat cancer cells in real time. The center is equipped with state-of-the-art technology and will be the first in Orange County to provide this treatment option.
Researchers at Waseda University developed a new technique using terahertz imaging to visualize the internal structure of the mouse cochlea with high resolution. The study successfully demonstrated the potential of THz imaging as a non-invasive diagnostic tool for auditory disorders and other medical applications.
The Chan Zuckerberg Initiative's CZ Biohub San Francisco and CZ Imaging Institute will join forces to develop novel imaging technologies that provide entirely new insights into human biology. This new Biohub aims to illuminate the dynamic architecture of living systems, making what was invisible visible, measurable and understandable.
Researchers explore new techniques to improve prostate cancer diagnosis and treatment, including dual-target PET/CT for enhanced lymph node staging and novel PSMA-targeted radioligands for more precise tumor targeting.
Researchers have developed a powerful imaging technology to study cellular metabolism, enabling the visualization of biomolecules' synthesis and turnover in live cells and organisms. Heavy-water probing allows for the tracking of metabolic dynamics, providing insights into aging and age-related diseases.
Researchers developed single-shot super-resolved fringe projection profilometry (SSSR-FPP) using deep learning to achieve 100,000 frames-per-second 3D imaging. This breakthrough offers new insights into ultra-fast dynamic processes and could revolutionize fields like mechanics and biology.
A nonlocal Huygens' meta-lens achieves high-quality-factor spin-multiplexing imaging with a high Q factor of 90. The proposed design enables simultaneous bright-field imaging and edge detection in the near-infrared region, improving imaging quality and accuracy.
PRISm is a form of Pre-Chronic Obstructive Pulmonary Disease (Pre-COPD) characterized by respiratory symptoms and reduced lung function. Imaging assessments, such as computed tomography scans and magnetic resonance imaging, play a crucial role in diagnosing and predicting the prognosis of PRISm.
Researchers at Tampere University and Kastler-Brossel Laboratory have demonstrated self-imaging of light in cylindrical systems, facilitating unprecedented control of light's structure. They also explore a new type of space-time duality, bridging different fields of optics.
Scientists achieved a quantum imaging breakthrough with an ultra-thin nonlinear metasurface, combining ghost imaging and all-optical scanning methods to reconstruct images with exceptional resolution. This approach eliminates the need for bulky nonlinear crystals and enables compact, highly tunable platforms for quantum imaging.
The project leverages super-radiance to enhance the brightness and emission rate of fluorophores, enabling high-throughput imaging and tracking of molecular processes. This could lead to breakthroughs in fields like cell biology, materials science, and nanotechnology.